|
|
|
11-50 employees
View all
|
|
biotechnology
|
|
305 College Rd East,Princeton,NJ,US
|
|
Advaxis (NASDAQ: ADXS) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. The Advaxis technology, using bioengineered live attenuated bacteria, Listeria monocytogenes (Lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
|
Advaxis, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{last} | [email protected] |
100%
|
The widely used Advaxis, Inc. email format is {last} (e.g. [email protected]) with 100% adoption across the company.
To contact Advaxis, Inc. customer service number in your country click here to find.
Daniel J O'connor is the CEO of Advaxis, Inc..
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.